3.25
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
View the full transcript and gain access to JoVE Core videos
Q1: How does GI pH affect drug ionization and absorption?
The gastrointestinal tract's pH varies from acidic in the stomach to slightly alkaline in the small intestine, directly affecting drug ionization. A drug's pKa and the absorption site's pH determine whether the drug remains unionized or becomes ionized. Unionized drugs are lipid-soluble and cross cell membranes efficiently, while ionized drugs dissolve poorly in lipid environments, reducing absorption.
Q2: Why do weak acids absorb better from the stomach while weak bases absorb better from the intestine?
Weak acids with pKa values between 2.5 and 7.5 remain largely unionized in the stomach's acidic environment, facilitating absorption. Conversely, weak bases with pKa values between 5 and 11 remain unionized in the intestine's alkaline environment. Each drug absorbs most efficiently where pH favors its unionized state, which is membrane-permeable.
Q3: What happens to very weak acids and bases during GI absorption?
Very weak acids with pKa above 8 and very weak bases with pKa below 5, such as phenytoin and caffeine, exist predominantly in their unionized form throughout the GI tract. These drugs exhibit rapid, pH-independent absorption because their lipid solubility remains high regardless of gastrointestinal pH changes.
Q4: How does lipophilicity influence drug absorption across the GI tract?
Lipophilicity, quantified as the partition coefficient (Log P or Kow), determines a drug's ability to dissolve in lipid-rich environments and cross cell membranes. Highly lipophilic drugs dissolve readily in lipid environments, facilitating passage through biological membranes and improving systemic absorption. An octanol/pH 7.4 buffer partition coefficient between 1 and 2 is optimal for passive membrane permeability.
Q5: What is the hydrophilic-lipophilic balance and why does it matter for drug absorption?
Hydrophilic-lipophilic balance (HLB) refers to a drug's need for adequate aqueous solubility to dissolve at the absorption site and sufficient lipid solubility to cross lipid-rich biomembranes. Only non-ionized drugs with high lipid solubility are efficiently absorbed into systemic circulation. This balance determines whether a drug can achieve optimal bioavailability in the gastrointestinal tract.
Q6: Why do stronger acids and bases have poor absorption in the GI tract?
Stronger acids with pKa less than 2.5 and stronger bases with pKa greater than 11 remain ionized throughout the entire GI tract. Their ionic forms cannot dissolve in lipid-rich environments or cross cell membranes efficiently through passive diffusion, resulting in poor absorption and limited bioavailability.
Q7: How does the relationship between pKa and pH determine drug dissolution?
When pH is far from a drug's pKa, the drug becomes highly ionized, increasing aqueous solubility but decreasing membrane permeability. Conversely, near the drug's pKa, the drug remains largely unionized, favoring absorption across biological membranes. Understanding this relationship helps optimize drug formulations for targeted dissolution and absorption through mechanisms of drug absorption paracellular transcellular and vesicular transport.